← Eichor
Study identifier: NCT05052736 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Non Invasive Neurostimulation Technology for the Treatment of Type I Complex Regional Pain Syndrome (CRPS I)

Condition: Type I Complex Regional Pain Syndrome  ·  Sponsor: University of Las Palmas de Gran Canaria

PhaseNA
Planned participants42
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Complex Regional Pain Syndrome (CRPS) / Complex Regional Pain Syndrome (CRPS) is a chronic neurological disorder that affects the extremities and is characterized by disabling pain, swelling, vasomotor instability, sudomotor abnormality, and impaired motor function; the duration and clinical magnitude is greater than expected, being divided into three stages of progression over time: Stage I: acute (0-3 months); Stage II: dystrophic (3-9 months); Stage 3: atrophic (9-18 months). The purpose of this study is to investigate the effect on complex pain syndrome using a conventional care protocol plus the application of non-invasive neuromodulation during compared to the effect of the same protocol plus placebo.

This description comes directly from the study's public registry record.

Talk to the study team

Aníbal Báez-Suárez, PhD  ·  +34 652077692  ·  anibal.baez@ulpgc.es

Aníbal Báez-Suárez, PhD  ·  +34652077692  ·  anibal.baez@ulpgc.es

Always discuss trial participation with your own doctor first.

Locations (1)

Aníbal Báez SuárezLas Palmas de Gran Canaria, Palmas, Las, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05052736